Endocrine complications, including diabetes and metabolic syndrome, are highly prevalent in childhood cancer survivors. These metabolic derangements may contribute to survivors’ risk of excess cardiovascular morbidity and premature mortality. This review summarizes existing knowledge on risk of diabetes and metabolic syndrome among childhood cancer survivors, focusing specifically on known risk factors, potential mechanisms, and screening recommendations. Early diagnosis via standardized risk-based screening can improve long-term outcomes in this population. Additional work is needed to elucidate the mechanisms underlying these metabolic complications and to inform the design of risk-reducing interventions and optimize long-term cardiometabolic health among survivors of childhood cancer.

1.
Phillips
SM
,
Padgett
LS
,
Leisenring
WM
,
Stratton
KK
,
Bishop
K
,
Krull
KR
, et al.
Survivors of childhood cancer in the United States: prevalence and burden of morbidity
.
Cancer Epidemiol Biomarkers Prev
.
2015
Apr
;
24
(
4
):
653
63
.
[PubMed]
1055-9965
2.
de Fine Licht
S
,
Rugbjerg
K
,
Gudmundsdottir
T
,
Bonnesen
TG
,
Asdahl
PH
,
Holmqvist
AS
, et al.;
ALiCCS study group
.
Long-term inpatient disease burden in the Adult Life after Childhood Cancer in Scandinavia (ALiCCS) study: A cohort study of 21,297 childhood cancer survivors
.
PLoS Med
.
2017
May
;
14
(
5
):
e1002296
.
[PubMed]
1549-1277
3.
Brignardello
E
,
Felicetti
F
,
Castiglione
A
,
Chiabotto
P
,
Corrias
A
,
Fagioli
F
,
Ciccone
G
,
Boccuzzi
G
:
Endocrine health conditions in adult survivors of childhood cancer: the need for specialized adult-focused follow-up clinics.
European journal of endocrinology / European Federation of Endocrine Societies
2013
;168:465-472.
4.
Mostoufi-Moab
S
,
Seidel
K
,
Leisenring
WM
,
Armstrong
GT
,
Oeffinger
KC
,
Stovall
M
, et al.
Endocrine Abnormalities in Aging Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study
.
J Clin Oncol
.
2016
Sep
;
34
(
27
):
3240
7
.
[PubMed]
0732-183X
5.
Ford
ES
.
Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence
.
Diabetes Care
.
2005
Jul
;
28
(
7
):
1769
78
.
[PubMed]
0149-5992
6.
Galassi
A
,
Reynolds
K
,
He
J
.
Metabolic syndrome and risk of cardiovascular disease: a meta-analysis
.
Am J Med
.
2006
Oct
;
119
(
10
):
812
9
.
[PubMed]
0002-9343
7.
Armstrong
GT
,
Chen
Y
,
Yasui
Y
,
Leisenring
W
,
Gibson
TM
,
Mertens
AC
, et al.
Reduction in Late Mortality among 5-Year Survivors of Childhood Cancer
.
N Engl J Med
.
2016
Mar
;
374
(
9
):
833
42
.
[PubMed]
0028-4793
8.
Long-term follow-up guidelines for survivors of childhood, adolescent, and young adult cancers Children's Oncology Group,
2013
,
9.
Meacham
LR
,
Sklar
CA
,
Li
S
,
Liu
Q
,
Gimpel
N
,
Yasui
Y
, et al.
Diabetes mellitus in long-term survivors of childhood cancer. Increased risk associated with radiation therapy: a report for the childhood cancer survivor study
.
Arch Intern Med
.
2009
Aug
;
169
(
15
):
1381
8
.
[PubMed]
0003-9926
10.
Holmqvist
AS
,
Olsen
JH
,
Andersen
KK
,
de Fine Licht
S
,
Hjorth
L
,
Garwicz
S
,
Moell
C
,
Anderson
H
,
Wesenberg
F
,
Tryggvadottir
L
,
Malila
N
,
Boice
JD
, Jr
.,
Hasle
H
,
Winther
JF
:
Adult life after childhood cancer in Scandinavia: diabetes mellitus following treatment for cancer in childhood.
European journal of cancer (Oxford, England : 1990)
2014
;50:1169-1175.
11.
Lega
IC
,
Pole
JD
,
Austin
PC
,
Lau
C
,
Nathan
PC
,
Baxter
NN
.
Diabetes Risk in Childhood Cancer Survivors: A Population-Based Study
.
Can J Diabetes
.
2018
Oct
;
42
(
5
):
533
9
.
[PubMed]
1499-2671
12.
de Vathaire
F
,
El-Fayech
C
,
Ben Ayed
FF
,
Haddy
N
,
Guibout
C
,
Winter
D
, et al.
Radiation dose to the pancreas and risk of diabetes mellitus in childhood cancer survivors: a retrospective cohort study
.
Lancet Oncol
.
2012
Oct
;
13
(
10
):
1002
10
.
[PubMed]
1470-2045
13.
van Nimwegen
FA
,
Schaapveld
M
,
Janus
CP
,
Krol
AD
,
Raemaekers
JM
,
Kremer
LC
, et al.
Risk of diabetes mellitus in long-term survivors of Hodgkin lymphoma
.
J Clin Oncol
.
2014
Oct
;
32
(
29
):
3257
63
.
[PubMed]
0732-183X
14.
Baker
KS
,
Ness
KK
,
Steinberger
J
,
Carter
A
,
Francisco
L
,
Burns
LJ
, et al.
Diabetes, hypertension, and cardiovascular events in survivors of hematopoietic cell transplantation: a report from the bone marrow transplantation survivor study
.
Blood
.
2007
Feb
;
109
(
4
):
1765
72
.
[PubMed]
0006-4971
15.
Chemaitilly
W
,
Boulad
F
,
Oeffinger
KC
,
Sklar
CA
.
Disorders of glucose homeostasis in young adults treated with total body irradiation during childhood: a pilot study
.
Bone Marrow Transplant
.
2009
Sep
;
44
(
6
):
339
43
.
[PubMed]
0268-3369
16.
Wei
C
,
Thyagiarajan
M
,
Hunt
L
,
Cox
R
,
Bradley
K
,
Elson
R
, et al.
Reduced beta-cell reserve and pancreatic volume in survivors of childhood acute lymphoblastic leukaemia treated with bone marrow transplantation and total body irradiation
.
Clin Endocrinol (Oxf)
.
2015
Jan
;
82
(
1
):
59
67
.
[PubMed]
0300-0664
17.
Wei
C
,
Unsworth
R
,
Davis
N
,
Cox
R
,
Bradley
K
,
Stevens
M
, et al.
Survivors of childhood leukaemia treated with haematopoietic stem cell transplantation and total body irradiation should undergo screening for diabetes by oral glucose tolerance tests
.
Diabet Med
.
2016
Oct
;
33
(
10
):
1347
51
.
[PubMed]
0742-3071
18.
Bunin
N
,
Aplenc
R
,
Kamani
N
,
Shaw
K
,
Cnaan
A
,
Simms
S
.
Randomized trial of busulfan vs total body irradiation containing conditioning regimens for children with acute lymphoblastic leukemia: a Pediatric Blood and Marrow Transplant Consortium study
.
Bone Marrow Transplant
.
2003
Sep
;
32
(
6
):
543
8
.
[PubMed]
0268-3369
19.
Bernard
F
,
Auquier
P
,
Herrmann
I
,
Contet
A
,
Poiree
M
,
Demeocq
F
, et al.
Health status of childhood leukemia survivors who received hematopoietic cell transplantation after BU or TBI: an LEA study
.
Bone Marrow Transplant
.
2014
May
;
49
(
5
):
709
16
.
[PubMed]
0268-3369
20.
Flandin
I
,
Hartmann
O
,
Michon
J
,
Pinkerton
R
,
Coze
C
,
Stephan
JL
, et al.
Impact of TBI on late effects in children treated by megatherapy for Stage IV neuroblastoma. A study of the French Society of Pediatric oncology
.
Int J Radiat Oncol Biol Phys
.
2006
Apr
;
64
(
5
):
1424
31
.
[PubMed]
0360-3016
21.
Li
R
,
Polishchuk
A
,
DuBois
S
,
Hawkins
R
,
Lee
SW
,
Bagatell
R
, et al.
Patterns of Relapse in High-Risk Neuroblastoma Patients Treated With and Without Total Body Irradiation
.
Int J Radiat Oncol Biol Phys
.
2017
Feb
;
97
(
2
):
270
7
.
[PubMed]
0360-3016
22.
Brauner
R
,
Adan
L
,
Souberbielle
JC
,
Esperou
H
,
Michon
J
,
Devergie
A
, et al.
Contribution of growth hormone deficiency to the growth failure that follows bone marrow transplantation
.
J Pediatr
.
1997
May
;
130
(
5
):
785
92
.
[PubMed]
0022-3476
23.
Chemaitilly
W
,
Boulad
F
,
Heller
G
,
Kernan
NA
,
Small
TN
,
O’Reilly
RJ
, et al.
Final height in pediatric patients after hyperfractionated total body irradiation and stem cell transplantation
.
Bone Marrow Transplant
.
2007
Jul
;
40
(
1
):
29
35
.
[PubMed]
0268-3369
24.
Darzy
KH
,
Shalet
SM
.
Radiation-induced growth hormone deficiency
.
Horm Res
.
2003
;
59
Suppl 1
:
1
11
.
[PubMed]
0301-0163
25.
Davis
NL
,
Stewart
CE
,
Moss
AD
,
Woltersdorf
WW
,
Hunt
LP
,
Elson
RA
, et al.
Growth hormone deficiency after childhood bone marrow transplantation with total body irradiation: interaction with adiposity and age
.
Clin Endocrinol (Oxf)
.
2015
Oct
;
83
(
4
):
508
17
.
[PubMed]
0300-0664
26.
Giorgiani
G
,
Bozzola
M
,
Locatelli
F
,
Picco
P
,
Zecca
M
,
Cisternino
M
, et al.
Role of busulfan and total body irradiation on growth of prepubertal children receiving bone marrow transplantation and results of treatment with recombinant human growth hormone
.
Blood
.
1995
Jul
;
86
(
2
):
825
31
.
[PubMed]
0006-4971
27.
Shalitin
S
,
Pertman
L
,
Yackobovitch-Gavan
M
,
Yaniv
I
,
Lebenthal
Y
,
Phillip
M
, et al.
Endocrine and Metabolic Disturbances in Survivors of Hematopoietic Stem Cell Transplantation in Childhood and Adolescence
.
Horm Res Paediatr
.
2018
;
89
(
2
):
108
21
.
[PubMed]
1663-2818
28.
Tauchmanovà
L
,
Selleri
C
,
Rosa
GD
,
Pagano
L
,
Orio
F
,
Lombardi
G
, et al.
High prevalence of endocrine dysfunction in long-term survivors after allogeneic bone marrow transplantation for hematologic diseases
.
Cancer
.
2002
Sep
;
95
(
5
):
1076
84
.
[PubMed]
0008-543X
29.
Wei
C
,
Albanese
A
.
Endocrine Disorders in Childhood Cancer Survivors Treated with Haemopoietic Stem Cell Transplantation
.
Children (Basel)
.
2014
Jun
;
1
(
1
):
48
62
.
[PubMed]
2227-9067
30.
Taskinen
M
,
Saarinen-Pihkala
UM
,
Hovi
L
,
Lipsanen-Nyman
M
.
Impaired glucose tolerance and dyslipidaemia as late effects after bone-marrow transplantation in childhood
.
Lancet
.
2000
Sep
;
356
(
9234
):
993
7
.
[PubMed]
0140-6736
31.
Neville
KA
,
Cohn
RJ
,
Steinbeck
KS
,
Johnston
K
,
Walker
JL
.
Hyperinsulinemia, impaired glucose tolerance, and diabetes mellitus in survivors of childhood cancer: prevalence and risk factors
.
J Clin Endocrinol Metab
.
2006
Nov
;
91
(
11
):
4401
7
.
[PubMed]
0021-972X
32.
Rajendran
R
,
Abu
E
,
Fadl
A
,
Byrne
CD
.
Late effects of childhood cancer treatment: severe hypertriglyceridaemia, central obesity, non alcoholic fatty liver disease and diabetes as complications of childhood total body irradiation
.
Diabet Med
.
2013
Aug
;
30
(
8
):
e239
42
.
[PubMed]
0742-3071
33.
Lorini
R
,
Cortona
L
,
Scaramuzza
A
,
De Stefano
P
,
Locatelli
F
,
Bonetti
F
, et al.
Hyperinsulinemia in children and adolescents after bone marrow transplantation
.
Bone Marrow Transplant
.
1995
Jun
;
15
(
6
):
873
7
.
[PubMed]
0268-3369
34.
Bizzarri
C
,
Pinto
RM
,
Ciccone
S
,
Brescia
LP
,
Locatelli
F
,
Cappa
M
.
Early and progressive insulin resistance in young, non-obese cancer survivors treated with hematopoietic stem cell transplantation
.
Pediatr Blood Cancer
.
2015
Sep
;
62
(
9
):
1650
5
.
[PubMed]
1545-5009
35.
Taskinen
M
,
Lipsanen-Nyman
M
,
Tiitinen
A
,
Hovi
L
,
Saarinen-Pihkala
UM
.
Insufficient growth hormone secretion is associated with metabolic syndrome after allogeneic stem cell transplantation in childhood
.
J Pediatr Hematol Oncol
.
2007
Aug
;
29
(
8
):
529
34
.
[PubMed]
1077-4114
36.
Wei
C
,
Thyagiarajan
MS
,
Hunt
LP
,
Shield
JP
,
Stevens
MC
,
Crowne
EC
.
Reduced insulin sensitivity in childhood survivors of haematopoietic stem cell transplantation is associated with lipodystropic and sarcopenic phenotypes
.
Pediatr Blood Cancer
.
2015
Nov
;
62
(
11
):
1992
9
.
[PubMed]
1545-5009
37.
Adachi
M
,
Oto
Y
,
Muroya
K
,
Hanakawa
J
,
Asakura
Y
,
Goto
H
:
Partial lipodystrophy in patients who have undergone hematopoietic stem cell transplantation during childhood: an institutional cross-sectional survey.
Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology
2017
;26:99-108.
38.
Mostoufi-Moab
S
,
Ginsberg
JP
,
Bunin
N
,
Zemel
BS
,
Shults
J
,
Thayu
M
, et al.
Body composition abnormalities in long-term survivors of pediatric hematopoietic stem cell transplantation
.
J Pediatr
.
2012
Jan
;
160
(
1
):
122
8
.
[PubMed]
0022-3476
39.
Mostoufi-Moab
S
,
Magland
J
,
Isaacoff
EJ
,
Sun
W
,
Rajapakse
CS
,
Zemel
B
,
Wehrli
F
,
Shekdar
K
,
Baker
J
,
Long
J
,
Leonard
MB
:
Adverse Fat Depots and Marrow Adiposity Are Associated With Skeletal Deficits and Insulin Resistance in Long-Term Survivors of Pediatric Hematopoietic Stem Cell Transplantation.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
2015
;30:1657-1666.
40.
Ketterl
TG
,
Chow
EJ
,
Leisenring
WM
,
Goodman
P
,
Koves
IH
,
Petryk
A
,
Steinberger
J
,
Baker
KS
: Adipokines, Inflammation, and Adiposity in Hematopoietic Cell Transplantation Survivors. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
2018
;24:622-626.
41.
Chow
EJ
,
Simmons
JH
,
Roth
CL
,
Baker
KS
,
Hoffmeister
PA
,
Sanders
JE
, et al.
Increased cardiometabolic traits in pediatric survivors of acute lymphoblastic leukemia treated with total body irradiation
.
Biol Blood Marrow Transplant
.
2010
Dec
;
16
(
12
):
1674
81
.
[PubMed]
1083-8791
42.
Carrel
AL
,
Allen
DB
.
Effects of growth hormone on body composition and bone metabolism
.
Endocrine
.
2000
Apr
;
12
(
2
):
163
72
.
[PubMed]
1355-008X
43.
Kavanagh
K
,
Dendinger
MD
,
Davis
AT
,
Register
TC
,
DeBo
R
,
Dugan
G
, et al.
Type 2 Diabetes is a Delayed Late Effect of Whole-Body Irradiation in Nonhuman Primates
.
Radiat Res
.
2015
Apr
;
183
(
4
):
398
406
.
[PubMed]
0033-7587
44.
Baillargeon
J
,
Langevin
AM
,
Mullins
J
,
Ferry
RJ
 Jr
,
DeAngulo
G
,
Thomas
PJ
, et al.
Transient hyperglycemia in Hispanic children with acute lymphoblastic leukemia
.
Pediatr Blood Cancer
.
2005
Dec
;
45
(
7
):
960
3
.
[PubMed]
1545-5009
45.
Lowas
SR
,
Marks
D
,
Malempati
S
.
Prevalence of transient hyperglycemia during induction chemotherapy for pediatric acute lymphoblastic leukemia
.
Pediatr Blood Cancer
.
2009
Jul
;
52
(
7
):
814
8
.
[PubMed]
1545-5009
46.
Banihashem
A
,
Ghasemi
A
,
Ghaemi
N
,
Moazzen
N
,
Amirabadi
A
.
Prevalence of transient hyperglycemia and diabetes mellitus in pediatric patients with acute leukemia
.
Iran J Ped Hematol Oncol
.
2014
;
4
(
1
):
5
10
.
[PubMed]
2008-8892
47.
Majhail
NS
,
Challa
TR
,
Mulrooney
DA
,
Baker
KS
,
Burns
LJ
:
Hypertension and diabetes mellitus in adult and pediatric survivors of allogeneic hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
2009
;15:1100-1107.
48.
Baker
KS
,
Chow
EJ
,
Goodman
PJ
,
Leisenring
WM
,
Dietz
AC
,
Perkins
JL
, et al.
Impact of treatment exposures on cardiovascular risk and insulin resistance in childhood cancer survivors
.
Cancer Epidemiol Biomarkers Prev
.
2013
Nov
;
22
(
11
):
1954
63
.
[PubMed]
1055-9965
49.
Chow
EJ
,
Pihoker
C
,
Hunt
K
,
Wilkinson
K
,
Friedman
DL
.
Obesity and hypertension among children after treatment for acute lymphoblastic leukemia
.
Cancer
.
2007
Nov
;
110
(
10
):
2313
20
.
[PubMed]
0008-543X
50.
Weiss
R
,
Dufour
S
,
Taksali
SE
,
Tamborlane
WV
,
Petersen
KF
,
Bonadonna
RC
, et al.
Prediabetes in obese youth: a syndrome of impaired glucose tolerance, severe insulin resistance, and altered myocellular and abdominal fat partitioning
.
Lancet
.
2003
Sep
;
362
(
9388
):
951
7
.
[PubMed]
0140-6736
51.
Weiss
R
,
Kaufman
FR
.
Metabolic complications of childhood obesity: identifying and mitigating the risk
.
Diabetes Care
.
2008
Feb
;
31
Suppl 2
:
S310
6
.
[PubMed]
0149-5992
52.
Yeckel
CW
,
Taksali
SE
,
Dziura
J
,
Weiss
R
,
Burgert
TS
,
Sherwin
RS
, et al.
The normal glucose tolerance continuum in obese youth: evidence for impairment in beta-cell function independent of insulin resistance
.
J Clin Endocrinol Metab
.
2005
Feb
;
90
(
2
):
747
54
.
[PubMed]
0021-972X
53.
Belle
FN
,
Kasteler
R
,
Schindera
C
,
Bochud
M
,
Ammann
RA
,
von der Weid
NX
, et al.;
Swiss Pediatric Oncology Group (SPOG)
.
No evidence of overweight in long-term survivors of childhood cancer after glucocorticoid treatment
.
Cancer
.
2018
Sep
;
124
(
17
):
3576
85
.
[PubMed]
0008-543X
54.
Raveendran
AV
,
Chacko
EC
,
Pappachan
JM
:
Non-pharmacological Treatment Options in the Management of Diabetes Mellitus.
European endocrinology
2018
;14:31-39.
55.
DeFronzo
RA
,
Ferrannini
E
,
Groop
L
,
Henry
RR
,
Herman
WH
,
Holst
JJ
, et al.
Type 2 diabetes mellitus
.
Nat Rev Dis Primers
.
2015
Jul
;
1
:
15019
.
[PubMed]
2056-676X
56.
Katsarou
A
,
Gudbjörnsdottir
S
,
Rawshani
A
,
Dabelea
D
,
Bonifacio
E
,
Anderson
BJ
, et al.
Type 1 diabetes mellitus
.
Nat Rev Dis Primers
.
2017
Mar
;
3
:
17016
.
[PubMed]
2056-676X
57.
Holmqvist
AS
,
Olsen
JH
,
Mellemkjaer
L
,
Garwicz
S
,
Hjorth
L
,
Moëll
C
, et al.;
ALiCCS study group
.
Autoimmune diseases in Adult Life after Childhood Cancer in Scandinavia (ALiCCS)
.
Ann Rheum Dis
.
2016
Sep
;
75
(
9
):
1622
9
.
[PubMed]
0003-4967
58.
Friedman
DN
,
Hilden
P
,
Moskowitz
CS
,
Wolden
SL
,
Tonorezos
ES
,
Antal
Z
, et al.
Insulin and glucose homeostasis in childhood cancer survivors treated with abdominal radiation: A pilot study
.
Pediatr Blood Cancer
.
2018
Nov
;
65
(
11
):
e27304
.
[PubMed]
1545-5009
59.
van Waas
M
,
Neggers
SJ
,
Raat
H
,
van Rij
CM
,
Pieters
R
,
van den Heuvel-Eibrink
MM
.
Abdominal radiotherapy: a major determinant of metabolic syndrome in nephroblastoma and neuroblastoma survivors
.
PLoS One
.
2012
;
7
(
12
):
e52237
.
[PubMed]
1932-6203
60.
Papazafiropoulou
AK
,
Papanas
N
,
Melidonis
A
,
Maltezos
E
.
Family History of Type 2 Diabetes: Does Having a Diabetic Parent Increase the Risk?
Curr Diabetes Rev
.
2017
;
13
(
1
):
19
25
.
[PubMed]
1573-3998
61.
Cook
S
,
Weitzman
M
,
Auinger
P
,
Nguyen
M
,
Dietz
WH
.
Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994
.
Arch Pediatr Adolesc Med
.
2003
Aug
;
157
(
8
):
821
7
.
[PubMed]
1072-4710
62.
Grundy
SM
,
Brewer
HB
 Jr
,
Cleeman
JI
,
Smith
SC
 Jr
,
Lenfant
C
;
American Heart Association
;
National Heart, Lung, and Blood Institute
.
Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition
.
Circulation
.
2004
Jan
;
109
(
3
):
433
8
.
[PubMed]
0009-7322
63.
Després
JP
,
Lemieux
I
.
Abdominal obesity and metabolic syndrome
.
Nature
.
2006
Dec
;
444
(
7121
):
881
7
.
[PubMed]
0028-0836
64.
Franssens
BT
,
Westerink
J
,
van der Graaf
Y
,
Nathoe
HM
,
Visseren
FL
;
SMART study group
.
Metabolic consequences of adipose tissue dysfunction and not adiposity per se increase the risk of cardiovascular events and mortality in patients with type 2 diabetes
.
Int J Cardiol
.
2016
Nov
;
222
:
72
7
.
[PubMed]
0167-5273
65.
Chemaitilly
W
,
Cohen
LE
,
Mostoufi-Moab
S
,
Patterson
BC
,
Simmons
JH
,
Meacham
LR
, et al.
Endocrine Late Effects in Childhood Cancer Survivors
.
J Clin Oncol
.
2018
Jul
;
36
(
21
):
2153
9
.
[PubMed]
0732-183X
66.
de Haas
EC
,
Oosting
SF
,
Lefrandt
JD
,
Wolffenbuttel
BH
,
Sleijfer
DT
,
Gietema
JA
.
The metabolic syndrome in cancer survivors
.
Lancet Oncol
.
2010
Feb
;
11
(
2
):
193
203
.
[PubMed]
1470-2045
67.
Meacham
LR
,
Chow
EJ
,
Ness
KK
,
Kamdar
KY
,
Chen
Y
,
Yasui
Y
, et al.
Cardiovascular risk factors in adult survivors of pediatric cancer—a report from the childhood cancer survivor study
.
Cancer Epidemiol Biomarkers Prev
.
2010
Jan
;
19
(
1
):
170
81
.
[PubMed]
1055-9965
68.
Saultier
P
,
Auquier
P
,
Bertrand
Y
,
Vercasson
C
,
Oudin
C
,
Contet
A
, et al.
Metabolic syndrome in long-term survivors of childhood acute leukemia treated without hematopoietic stem cell transplantation: an L.E.A. study
.
Haematologica
.
2016
Dec
;
101
(
12
):
1603
10
.
[PubMed]
0390-6078
69.
Smith
WA
,
Li
C
,
Nottage
KA
,
Mulrooney
DA
,
Armstrong
GT
,
Lanctot
JQ
, et al.
Lifestyle and metabolic syndrome in adult survivors of childhood cancer: a report from the St. Jude Lifetime Cohort Study
.
Cancer
.
2014
Sep
;
120
(
17
):
2742
50
.
[PubMed]
0008-543X
70.
Talvensaari
KK
,
Lanning
M
,
Tapanainen
P
,
Knip
M
.
Long-term survivors of childhood cancer have an increased risk of manifesting the metabolic syndrome
.
J Clin Endocrinol Metab
.
1996
Aug
;
81
(
8
):
3051
5
.
[PubMed]
0021-972X
71.
van Waas
M
,
Neggers
SJ
,
Pieters
R
,
van den Heuvel-Eibrink
MM
:
Components of the metabolic syndrome in 500 adult long-term survivors of childhood cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO
2010
;21:1121-1126.
72.
Nottage
KA
,
Ness
KK
,
Li
C
,
Srivastava
D
,
Robison
LL
,
Hudson
MM
.
Metabolic syndrome and cardiovascular risk among long-term survivors of acute lymphoblastic leukaemia - From the St. Jude Lifetime Cohort
.
Br J Haematol
.
2014
May
;
165
(
3
):
364
74
.
[PubMed]
0007-1048
73.
Oudin
C
,
Simeoni
MC
,
Sirvent
N
,
Contet
A
,
Begu-Le Coroller
A
,
Bordigoni
P
, et al.
Prevalence and risk factors of the metabolic syndrome in adult survivors of childhood leukemia
.
Blood
.
2011
Apr
;
117
(
17
):
4442
8
.
[PubMed]
0006-4971
74.
Tonorezos
ES
,
Robien
K
,
Eshelman-Kent
D
,
Moskowitz
CS
,
Church
TS
,
Ross
R
, et al.
Contribution of diet and physical activity to metabolic parameters among survivors of childhood leukemia
.
Cancer Causes Control
.
2013
Feb
;
24
(
2
):
313
21
.
[PubMed]
0957-5243
75.
van Waas
M
,
Neggers
SJ
,
Uitterlinden
AG
,
Blijdorp
K
,
van der Geest
IM
,
Pieters
R
,
van den Heuvel-Eibrink
MM
:
Treatment factors rather than genetic variation determine metabolic syndrome in childhood cancer survivors.
European journal of cancer (Oxford, England : 1990)
2013
;49:668-675.
76.
Oeffinger
KC
,
Adams-Huet
B
,
Victor
RG
,
Church
TS
,
Snell
PG
,
Dunn
AL
, et al.
Insulin resistance and risk factors for cardiovascular disease in young adult survivors of childhood acute lymphoblastic leukemia
.
J Clin Oncol
.
2009
Aug
;
27
(
22
):
3698
704
.
[PubMed]
0732-183X
77.
Tonorezos
ES
,
Vega
GL
,
Sklar
CA
,
Chou
JF
,
Moskowitz
CS
,
Mo
Q
, et al.
Adipokines, body fatness, and insulin resistance among survivors of childhood leukemia
.
Pediatr Blood Cancer
.
2012
Jan
;
58
(
1
):
31
6
.
[PubMed]
1545-5009
78.
Oudin
C
,
Berbis
J
,
Bertrand
Y
,
Vercasson
C
,
Thomas
F
,
Chastagner
P
, et al.
Prevalence and characteristics of metabolic syndrome in adults from the French childhood leukemia survivors’ cohort: a comparison with controls from the French population
.
Haematologica
.
2018
Apr
;
103
(
4
):
645
54
.
[PubMed]
0390-6078
79.
Gurney
JG
,
Ness
KK
,
Sibley
SD
,
O’Leary
M
,
Dengel
DR
,
Lee
JM
, et al.
Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemia
.
Cancer
.
2006
Sep
;
107
(
6
):
1303
12
.
[PubMed]
0008-543X
80.
Airaghi
L
,
Usardi
P
,
Forti
S
,
Orsatti
A
,
Baldini
M
,
Annaloro
C
, et al.
A comparison between metabolic syndrome post-hematopoietic stem cell transplantation and spontaneously occurring metabolic syndrome
.
J Endocrinol Invest
.
2011
Jan
;
34
(
1
):
e6
11
.
[PubMed]
0391-4097
81.
Baker
KS
,
Chow
E
,
Steinberger
J
.
Metabolic syndrome and cardiovascular risk in survivors after hematopoietic cell transplantation
.
Bone Marrow Transplant
.
2012
May
;
47
(
5
):
619
25
.
[PubMed]
0268-3369
82.
Majhail
NS
,
Flowers
ME
,
Ness
KK
,
Jagasia
M
,
Carpenter
PA
,
Arora
M
, et al.
High prevalence of metabolic syndrome after allogeneic hematopoietic cell transplantation
.
Bone Marrow Transplant
.
2009
Jan
;
43
(
1
):
49
54
.
[PubMed]
0268-3369
83.
Frisk
P
,
Rössner
SM
,
Norgren
S
,
Arvidson
J
,
Gustafsson
J
.
Glucose metabolism and body composition in young adults treated with TBI during childhood
.
Bone Marrow Transplant
.
2011
Oct
;
46
(
10
):
1303
8
.
[PubMed]
0268-3369
84.
Armenian
SH
,
Sun
CL
,
Vase
T
,
Ness
KK
,
Blum
E
,
Francisco
L
, et al.
Cardiovascular risk factors in hematopoietic cell transplantation survivors: role in development of subsequent cardiovascular disease
.
Blood
.
2012
Nov
;
120
(
23
):
4505
12
.
[PubMed]
0006-4971
85.
Järvelä
LS
,
Kemppainen
J
,
Niinikoski
H
,
Hannukainen
JC
,
Lähteenmäki
PM
,
Kapanen
J
, et al.
Effects of a home-based exercise program on metabolic risk factors and fitness in long-term survivors of childhood acute lymphoblastic leukemia
.
Pediatr Blood Cancer
.
2012
Jul
;
59
(
1
):
155
60
.
[PubMed]
1545-5009
86.
Slater
ME
,
Ross
JA
,
Kelly
AS
,
Dengel
DR
,
Hodges
JS
,
Sinaiko
AR
, et al.
Physical activity and cardiovascular risk factors in childhood cancer survivors
.
Pediatr Blood Cancer
.
2015
Feb
;
62
(
2
):
305
10
.
[PubMed]
1545-5009
87.
Slater
ME
,
Steinberger
J
,
Ross
JA
,
Kelly
AS
,
Chow
EJ
,
Koves
IH
,
Hoffmeister
P
,
Sinaiko
AR
,
Petryk
A
,
Moran
A
,
Lee
J
,
Chow
LS
,
Baker
KS
: Physical Activity, Fitness, and Cardiometabolic Risk Factors in Adult Survivors of Childhood Cancer with a History of Hematopoietic Cell Transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
2015
;21:1278-1283.
88.
Kremer
LC
,
Mulder
RL
,
Oeffinger
KC
,
Bhatia
S
,
Landier
W
,
Levitt
G
, et al.;
International Late Effects of Childhood Cancer Guideline Harmonization Group
.
A worldwide collaboration to harmonize guidelines for the long-term follow-up of childhood and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group
.
Pediatr Blood Cancer
.
2013
Apr
;
60
(
4
):
543
9
.
[PubMed]
1545-5009
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.